Roger W. Rose

Chief Executive Officer at Pinnacle Transplant Technologies, Inc.

Roger W. Rose

Roger W. Rose

Chief Executive Officer at Pinnacle Transplant Technologies, Inc.

Overview
Career Highlights

RTI Donor Services, Inc.
Pinnacle Transplant Technologies, Inc.

RelSci Relationships

1005

Birthday

1960

Age

59

Relationships
RelSci Relationships are individuals Roger W. Rose likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer & Director at Pinnacle Transplant Technologies, Inc.

Relationship likelihood: Strong

Medical Director at RTI Surgical, Inc.

Relationship likelihood: Strong

Executive Chairman & Chief Executive Officer at Catalyst Orthoscience LLC

Relationship likelihood: Strong

Former Vice President & Chief Financial Officer at RTI Surgical, Inc.

Relationship likelihood: Strong

Former Vice President of Quality Assurance & Regulatory Affairs at RTI Surgical, Inc.

Relationship likelihood: Strong

President at Pinnacle Transplant Technologies LLC

Relationship likelihood: Strong

Vice President of Accreditation & Standards at American Association of Tissue Banks

Relationship likelihood: Strong

Former Vice President-Human Resources & Organizational Development at Regeneration Technologies, Inc.

Relationship likelihood: Strong

Senior Vice President, Sales at Vivex Biomedical, Inc.

Relationship likelihood: Strong

Former Vice President, Operations at Regeneration Technologies, Inc.

Relationship likelihood: Strong

Paths to Roger W. Rose
Potential Connections via
Relationship Science
You
Roger W. Rose
Chief Executive Officer at Pinnacle Transplant Technologies, Inc.
Education
B.A., Business Administration

Western Michigan University is a national research university enrolling nearly 25,000 students from across the United States and more than 100 other countries. Founded in 1903, it is a learner-centered, discovery-driven and globally engaged public university that stands out among America's more than 5,000 higher education institutions.

Attendee

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Attendee

UCLA's primary purpose as a public research university is the creation, dissemination, preservation and application of knowledge for the betterment of our global society. To fulfill this mission, UCLA is committed to academic freedom in its fullest terms: We value open access to information, free and lively debate conducted with mutual respect for individuals, and freedom from intolerance. In all of our pursuits, we strive at once for excellence and diversity, recognizing that openness and inclusion produce true quality. These values underlie our three institutional responsibilities. Learning and teaching at UCLA are guided by the belief that undergraduate, graduate and professional school students and their teachers belong to a community of scholars. This community is dedicated to providing students with a foundational understanding of a broad range of disciplines followed by the opportunity for in-depth study in a chosen discipline. All members of the community are engaged together in discovering and advancing knowledge and practice. Learning occurs not only in the classroom but also through engagement in campus life and in communities and organizations beyond the university.

Career History
Chief Executive Officer
2019 - Current

Pinnacle Transplant Technologies, Inc. manufactures allograft tissue for transplantation. It uses technology that demineralizes bones with minimal manipulation and serves tissue banks in the biotechnology industry. The company was founded in 2010 and is headquartered in Phoenix, AZ.

President
2002 - 2017
Executive Vice President & Chief Commercial Officer
2002 - 2017

A leading provider of sterile biologic implants around the world, RTI Biologics, Inc. is at the forefront of tissue-based innovations that repair and support the natural healing of human bone and tissues. We continue to break new ground with developments that are changing regenerative medicine. RTI prepares human donated tissue and bovine tissue for transplantation through extensive testing and screening, precision shaping and proprietary, validated sterilization processes. These allograft and xenograft implants are used in spine, sports medicine, orthopedic, dental and other specialty surgeries. RTI’s innovations continuously raise the bar of science and safety for biologics—from being the first company to offer precision-tooled bone implants and assembled technology to maximize each gift of donation, to inventing validated sterilization processes that include viral inactivation steps. Two such processes—the BioCleanse® and Tutoplast® Tissue Sterilization Processes—sterilize tissue, are clinically successful and are scientifically proven to address donor-to-recipient disease transmission risk while preserving tissue strength and biocompatibility. These processes have a proven record of more than four million implants distributed with zero incidence of allograft-associated infection. Allograft is tissue that has been donated upon death by the donor. RTI honors the gift of tissue donation by treating the tissue with respect, by finding new ways to use the tissue to help patients and by helping as many patients as possible from each donation. The company is leading the evolution of biologics once again by offering a bovine based biological matrix, providing surgeons an expanded supply of safe, sterile tissue for their patients.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Roger W. Rose. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Roger W. Rose's profile does not indicate a business or promotional relationship of any kind between RelSci and Roger W. Rose.